Literature DB >> 17347526

A bias against disconfirmatory evidence is associated with delusion proneness in a nonclinical sample.

Todd S Woodward1, Lisa Buchy, Steffen Moritz, Mario Liotti.   

Abstract

Previous work has suggested that a bias against disconfirmatory evidence (BADE) may be associated with the schizophrenia spectrum. The current investigation focused on whether a BADE (1) overlaps with traditional measures of memory and executive functions or selectively taps into a unique aspect of cognition and (2) is correlated with delusional ideation but not with other aspects of schizotypy. Sixty-eight undergraduate students were administered the Schizotypal Personality Questionnaire (SPQ), the BADE test, the Rey Auditory Verbal Learning Test (RAVLT), the Wisconsin Card Sorting Test (WCST), the Trail Making Tests A and B (TMT), and tests used to estimate IQ. Factor analysis of all cognition measures resulted in a 6-factor solution, 4 of which reflected the 4 domains of neuropsychological tests (WCST, RAVLT, TMT, and IQ), and 2 of which reflected different aspects of the BADE test: Initial Belief and Integration of Disconfirmatory Evidence. This solution suggests that BADE measures were independent from the other cognitive domains measured. Integration of Disconfirmatory Evidence was the only factor that correlated with delusion-content subscales of the SPQ, providing support for the contribution of a BADE to delusional ideation.

Entities:  

Mesh:

Year:  2007        PMID: 17347526      PMCID: PMC2632321          DOI: 10.1093/schbul/sbm013

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  14 in total

1.  A generalized bias against disconfirmatory evidence in schizophrenia.

Authors:  Steffen Moritz; Todd S Woodward
Journal:  Psychiatry Res       Date:  2006-05-02       Impact factor: 3.222

2.  A cognitive bias against disconfirmatory evidence (BADE) is associated with schizotypy.

Authors:  Lisa Buchy; Todd S Woodward; Mario Liotti
Journal:  Schizophr Res       Date:  2007-01-09       Impact factor: 4.939

3.  The contribution of a cognitive bias against disconfirmatory evidence (BADE) to delusions in schizophrenia.

Authors:  Todd S Woodward; Steffen Moritz; Carrie Cuttler; Jennifer C Whitman
Journal:  J Clin Exp Neuropsychol       Date:  2006-05       Impact factor: 2.475

Review 4.  The relevance of irrelevance to schizophrenia.

Authors:  Nicola S Gray; Robert J Snowden
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

5.  The contribution of a cognitive bias against disconfirmatory evidence (BADE) to delusions: a study in an Asian sample with first episode schizophrenia spectrum disorders.

Authors:  Todd S Woodward; Steffen Moritz; Eric Y H Chen
Journal:  Schizophr Res       Date:  2006-03-02       Impact factor: 4.939

6.  The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria.

Authors:  A Raine
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

7.  Cognitive-perceptual, interpersonal, and disorganized features of schizotypal personality.

Authors:  A Raine; C Reynolds; T Lencz; A Scerbo; N Triphon; D Kim
Journal:  Schizophr Bull       Date:  1994       Impact factor: 9.306

Review 8.  The self, attributional processes and abnormal beliefs: towards a model of persecutory delusions.

Authors:  R P Bentall; P Kinderman; S Kaney
Journal:  Behav Res Ther       Date:  1994-03

9.  Schizotypy and conditional reasoning.

Authors:  Joselyn L Sellen; Mike Oaksford; Nicola S Gray
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

10.  The contribution of metamemory deficits to schizophrenia.

Authors:  Steffen Moritz; Todd S Woodward
Journal:  J Abnorm Psychol       Date:  2006-02
View more
  25 in total

1.  Erotomania and Recommendations for Treatment.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2016-06

Review 2.  Dual-process theory, conflict processing, and delusional belief.

Authors:  Michael V Bronstein; Gordon Pennycook; Jutta Joormann; Philip R Corlett; Tyrone D Cannon
Journal:  Clin Psychol Rev       Date:  2019-06-12

3.  A distinct inferential mechanism for delusions in schizophrenia.

Authors:  Seth C Baker; Anna B Konova; Nathaniel D Daw; Guillermo Horga
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

4.  Association of Schizotypy With Dimensions of Cognitive Control: A Meta-Analysis.

Authors:  Maria Steffens; Inga Meyhöfer; Kaja Fassbender; Ulrich Ettinger; Joseph Kambeitz
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

5.  Self-reported Cognitive Biases Moderate the Associations Between Social Stress and Paranoid Ideation in a Virtual Reality Experimental Study.

Authors:  Roos Pot-Kolder; Wim Veling; Jacqueline Counotte; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

6.  Elucidating the black box from stress to paranoia.

Authors:  Steffen Moritz; Pia Burnette; Sabine Sperber; Ulf Köther; Marion Hagemann-Goebel; Maike Hartmann; Tania M Lincoln
Journal:  Schizophr Bull       Date:  2010-05-31       Impact factor: 9.306

7.  Dopamine effects on evidence gathering and integration.

Authors:  Christina Andreou; Brooke C Schneider; Vivien Braun; Katharina Kolbeck; Jürgen Gallinat; Steffen Moritz
Journal:  J Psychiatry Neurosci       Date:  2015-11       Impact factor: 6.186

8.  Functional Brain Networks Underlying Evidence Integration and Delusions in Schizophrenia.

Authors:  Katie M Lavigne; Mahesh Menon; Todd S Woodward
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

9.  Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study.

Authors:  Christina Andreou; Steffen Moritz; Kristina Veith; Ruth Veckenstedt; Dieter Naber
Journal:  Schizophr Bull       Date:  2013-05-09       Impact factor: 9.306

Review 10.  Neuropsychological aspects of delusional disorder.

Authors:  Mona Abdel-Hamid; Martin Brüne
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.